Trial Profile
A proof of concept study of DCP-001 for the treatment of Multiple Myeloma.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Vididencel (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Proof of concept
- 17 Feb 2016 New trial record